PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 154 filers reported holding PROGENICS PHARMACEUTICALS IN in Q4 2017. The put-call ratio across all filers is 1.56 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $115,000 | -77.4% | 22,858 | -72.2% | 0.00% | -100.0% |
| Q2 2019 | $508,000 | -65.0% | 82,304 | -73.7% | 0.00% | -50.0% |
| Q1 2019 | $1,451,000 | -37.1% | 312,635 | -43.0% | 0.00% | -50.0% |
| Q4 2018 | $2,306,000 | +140.2% | 548,953 | +360.0% | 0.00% | +300.0% |
| Q2 2018 | $960,000 | +344.4% | 119,350 | +312.3% | 0.00% | – |
| Q1 2018 | $216,000 | +27.8% | 28,950 | +2.0% | 0.00% | – |
| Q4 2017 | $169,000 | -72.9% | 28,385 | -69.1% | 0.00% | -100.0% |
| Q2 2017 | $624,000 | -75.2% | 91,911 | -65.5% | 0.00% | -80.0% |
| Q1 2017 | $2,515,000 | -13.0% | 266,459 | -20.4% | 0.01% | -16.7% |
| Q4 2016 | $2,892,000 | -81.1% | 334,670 | -86.1% | 0.01% | -76.9% |
| Q3 2016 | $15,279,000 | +60.0% | 2,413,708 | +6.7% | 0.03% | +18.2% |
| Q2 2016 | $9,550,000 | -17.6% | 2,262,997 | -14.8% | 0.02% | -24.1% |
| Q1 2016 | $11,584,000 | -16.8% | 2,656,951 | +17.0% | 0.03% | 0.0% |
| Q4 2015 | $13,920,000 | +6.7% | 2,270,725 | -0.4% | 0.03% | +16.0% |
| Q3 2015 | $13,044,000 | -12.8% | 2,280,423 | +13.8% | 0.02% | -10.7% |
| Q2 2015 | $14,954,000 | +589.1% | 2,004,526 | +452.5% | 0.03% | +600.0% |
| Q1 2015 | $2,170,000 | -22.1% | 362,797 | -1.6% | 0.00% | -33.3% |
| Q4 2014 | $2,786,000 | +388.8% | 368,523 | +178.9% | 0.01% | +200.0% |
| Q2 2014 | $570,000 | +22.1% | 132,156 | +51.0% | 0.00% | +100.0% |
| Q4 2013 | $467,000 | +209.3% | 87,535 | +158.4% | 0.00% | – |
| Q2 2013 | $151,000 | – | 33,877 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|